RA PHARMACEUTICALS INC (RARX)
Institutional ownership reported to the SEC as of Q2 2020, across 7 quarters.
1
Reporting holders
$32.0K
Reported value
0.0%
Held as options
-149
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | $32.0K | 266 | 0.00% | 7q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2020 | 1 | $32.0K | 266 | 0 | 0 | 0 | 0.0% |
| Q1 2020 | 150 | $2.5B | 51,427,521 | 32 | 49 | 47 | 1.4% |
| Q4 2019 | 152 | $2.4B | 50,545,654 | 75 | 29 | 36 | 1.1% |
| Q3 2019 | 120 | $1.1B | 48,415,373 | 18 | 57 | 27 | 0.1% |
| Q2 2019 | 119 | $1.3B | 43,117,045 | 19 | 54 | 30 | 0.5% |
| Q1 2019 | 123 | $900.3M | 40,191,111 | 34 | 42 | 30 | 0.0% |
| Q4 2018 | 95 | $642.4M | 38,268,731 | 6 | 0 | 2 | 0.1% |